Abstract:Background Allergic asthma is associated with airway inflammation and hyperresponsiveness caused by dysregulated production of cytokines secreted by allergen-specific helper T-type 2 (Th2) cells. The linker for activation of T cells (LAT) is a membrane-associated adaptor protein, which has been shown to take part in regulating T cell receptor (TCR) signaling and T cell homeostasis. In this study, we established an asthmatic mouse model to examine the changes in LAT levels during allergic airway disease and the effects of LAT transgenic expression on airway inflammation.Methods T cells from mouse lung tissues were isolated from allergen challenged (ovalbumin (OVA)) and control mice, and the purity of these isolated T cells was examined by fluorescence-activated cell sorter (FAGS). Semi-quantitative RT-PCR and Western blotting were used to detect the expression of the LAT gene and LAT protein, respectively. After an intranasally administered mixture of pCMV-HA-LAT plasmid and Lipofectamine 2000, 24 hours before and 72 hours after allergen challenge, the BALF cell count and the differential cytologies were studied. In addition, IL-4 and IFN-gamma levels in the BALF were determined by ELISA, and pathological changes in lung tissues were observed.Results LAT protein and mRNA expression were decreased in lung T cells in a mouse model of allergen-induced airway disease. After intranasal administration of pCMV-HA-LAT, histopathological examination of the lungs showed that intervention with LAT overexpression prevented mice from developing airway inflammation, and the number of total cells, eosinophils, neutrophils, and lymphocytes in the BALF was reduced significantly compared with the OVA sensitized and challenged group. In addition, the Th2 cytokine IL-4 decreased, while the Th1 cytokine IFN-gamma increased compared to the OVA sensitized and challenged group or the OVA sensitized group plus pCMV-HA treatment.Conclusion This study demonstrates that LAT might effectively diminish Th2 cytokine responses, lung histopathological changes and lung inflammation to allergen challenge in a model of experimentally induced asthma. Chin Med J 2010;123(19):2676-2681

CD4+ T cell-derived IFN-γ and LIGHT synergistically upregulate chemokine production from airway smooth muscle cells

Lymphotoxin beta receptor signaling directly controls airway smooth muscle deregulation and asthmatic lung dysfunction

Induction of a memory‐like CD4+ T‐cell phenotype by airway smooth muscle cells

T cell and airway smooth muscle interaction: a key driver of asthmatic airway inflammation and remodeling

Author Response for "induction of a Memory‐like CD4+ T‐cell Phenotype by Airway Smooth Muscle Cells"

Inflammatory Mediators Mediate Airway Smooth Muscle Contraction Through a G Protein-Coupled Receptor–transmembrane Protein 16A–voltage-Dependent Ca2+ Channel Axis and Contribute to Bronchial Hyperresponsiveness in Asthma

CD4(+) T-cell cytokine production within a ay mucosal DC-T-cell clusters drives the local recruitment of myeloid effector cells in response to house dust mite allergen

Allergen-Induced CD4+ T Cell Cytokine Production within Airway Mucosal Dendritic Cell-T Cell Clusters Drives the Local Recruitment of Myeloid Effector Cells.

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

Il4 And Il-17a Provide A Th2/Th17-Polarized Inflammatory Milieu In Favor Of Tgf-Beta 1 To Induce Bronchial Epithelial-Mesenchymal Transition (Emt)

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways

Interleukin-17A Promotes Airway Remodeling in Chronic Obstructive Pulmonary Disease by Activating C-X-C Motif Chemokine Ligand 12 Secreted by Lung Fibroblasts

Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness

Linker for Activation of T Cells Contributes to Airway Inflammation in an Asthmatic Mouse Model

Lung CD4+ resident memory T cells use airway secretory cells to stimulate and regulate neutrophilic allergic airways disease.

MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells

Preferential JAK‐3 Mediated MUC8 Enhancement in Airway Epithelial Cells Upon Th2 Cytokine Stimulus

TH17 Cytokines Induce Human Airway Smooth Muscle Cell Migration

CXCR4 Inhibitor Attenuates Allergen-Induced Lung Inflammation by Down-Regulating MMP-9 and ERK1/2.

IL-4Rα signaling in CD4+CD25+FoxP3+ T regulatory cells restrains airway inflammation via limiting local tissue IL-33